Health Care - Spark Newswire

1 minute read

Omeros’ Narsoplimab Associated With Improvement In Organ Function In Stem Cell Transplant Patients

Today, 10:47 AM

Omeros Corporation (NASDAQ:OMER) has announced the presentation of data on organ function improvement from its pivotal trial of narsoplimab for the…

OMER

1 minute read

Terns Shares Drop After Mixed Results From Mid-Stage NASH Trial With FXR Agonist

By Vandana Singh

Today, 10:47 AM

Terns Pharmaceuticals Inc (NASDAQ:TERN) reported top-line results from the Phase 2a LIFT trial of TERN-101, a liver-distributed farnesoid X receptor (FXR)…

TERN

1 minute read

Brooklyn ImmunoTherapeutics Stock Rises After Novellus Therapeutics Buyout Deal

By Vandana Singh

Today, 10:47 AM

Brooklyn ImmunoTherapeutics LLC (NYSE:BTX) has executed a non-binding letter of intent to acquire Novellus Therapeutics, a company developing engineered mesenchymal stem…

BTX

2 minute read

Philips Recalls Ventilators And Sleep Apnea Devices Due To Possible Health Risks

By Phil Hall

Today, 10:47 AM

The Dutch medical equipment firm Koninklijke Philips NV (OTC: RYLPF) has recalled several of its sleep apnea and respiratory care devices due to potential health risks.

RYLPF

1 minute read

Cocrystal Pharma’s Preclinical Protease Inhibitor Effective Against Original, Two Variant COVID-19 Strains

By Vandana Singh

Today, 10:47 AM

Cocrystal Pharma Inc (NASDAQ:COCP) has announced laboratory-based results for its lead preclinical SARS-CoV-2 3CL protease inhibitor, CDI-45205. A third-party laboratory contracted…

COCP

1 minute read

Lipocine To Start Testing Neuro-Steroid Candidate In Postpartum Depression Patients

By Vandana Singh

Today, 10:47 AM

The FDA has signed off Lipocine Inc’s (NASDAQ:LPCN) Investigational New Drug Application (IND) to initiate a Phase 2 study to evaluate…

LPCN

1 minute read

G1 Therapeutics Starts Mid-Stage Bladder Cancer Trial With Cosela

By Vandana Singh

Today, 10:47 AM

G1 Therapeutics Inc (NASDAQ:GTHX) has initiated the PRESERVE 3 Phase 2 study evaluating Cosela (trilaciclib) in patients with untreated, locally advanced,…

GTHX

1 minute read

EyeGate Pharma Stock Jumps On Initiation Of Proof Of Concept Trial With DHODH Inhibitor In Ophthalmology Indications

By Vandana Singh

Today, 10:47 AM

EyeGate Pharmaceuticals Inc (NASDAQ:EYEG) has dosed the patient in Phase 2 proof-of-concept study evaluating its lead product candidate, PP-001, in patients…

EYEG

1 minute read

RAPT Therapeutics Stock Soars As Atopic Dermatitis Candidate Shows Promising Action In Early-Stage Study

By Vandana Singh

Today, 10:47 AM

RAPT Therapeutics Inc (NASDAQ:RAPT) has announced topline results from its Phase 1b trial of RPT193 as monotherapy for moderate-to-severe atopic dermatitis…

RAPT

1 minute read

Why Is Enochian BioSciences (ENOB) Stock Surging Today?

By Vandana Singh

Today, 10:47 AM

The FDA has accepted Enochian BioSciences Inc’s (NASDAQ:ENOB) pre-IND (Investigational New Drug) request for a potential functional cure or treatment of…

ENOB